ClassID:

95301

C07D417/12 - page 5 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#1201
20210008023
2021-01-14

N4-phenyl-quinazoline-4 -amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

#1202
20210007356
2021-01-14

IMIDE DERIVATIVE AND FUNGICIDE CONTAINING SAID DERIVATIVE AS ACTIVE INGREDIENT

#1203
20210002296
2021-01-07

Protein degraders and uses thereof

#1204
20210002274
2021-01-07

Sulfonyl acetamides as NLRP3 inhibitors

#1205
20210002269
2021-01-07

Aminothiazole compounds as inhibitors of CTPS1

#1206
20210002268
2021-01-07

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

#1207
20210002267
2021-01-07

NOVEL FORMULATION OF MELOXICAM

#1208
20210002253
2021-01-07

Aryl cyclopropyl-amino-isoquinolinyl amide compounds

#1209
20210002233
2021-01-07

PKM2 MODULATORS AND METHODS FOR THEIR USE

#1210
20200407327
2020-12-31

Tead inhibitors and uses thereof

#1211
20200407320
2020-12-31

Heterocyclic compounds for the treatment of neurological and psychological disorders

#1212
20200407316
2020-12-31

SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

#1213
20200399280
2020-12-24

3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#1214
20200399264
2020-12-24

4-SUBSTITUTED-2-THIAZOLE AMIDES AS ANTIVIRAL AGENTS

#1215
20200399235
2020-12-24

Sulfonamide compound or salt thereof

#1216
20200399218
2020-12-24

Antimicrobial compounds, compositions, and articles of manufacture for selectively inhibiting pathogenic microbes

#1217
20200399217
2020-12-24

Methods and compositions for selectively inhibiting pathogenic microbes

#1218
20200392161
2020-12-17

SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF

#1219
20200392140
2020-12-17

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

#1220
20200392131
2020-12-17

Compounds and methods for the enhanced degradation of targeted proteins

#1221
20200392108
2020-12-17

ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS AND METHODS

#1222
20200392081
2020-12-17

NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF

#1223
20200392077
2020-12-17

4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

#1224
20200385375
2020-12-10

Acid addition salts of piperazine derivatives

#1225
20200385374
2020-12-10

Imidazole-based anticancer agents and derivatives thereof, and methods of making and using same

#1226
20200385369
2020-12-10

NEW BENZIMIDAZOLES DERIVATIVES AS TEC KINASES FAMILY INHIBITORS

#1227
20200385354
2020-12-10

Quinoline sulfonamide compounds and their use as antibacterial agents

#1228
20200383330
2020-12-10

Insecticidal compounds based on isoxazoline derivatives

#1229
20200377511
2020-12-03

Bicyclic-fused heteroaryl or aryl compounds

#1230
20200377501
2020-12-03

DEGRADERS OF EGFR AND METHODS OF USE THEREOF

#1231
20200377495
2020-12-03

Polymorphic forms of Dasatinib

#1232
20200377494
2020-12-03

COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY AND DEGENERATIVE DISORDER

#1233
20200377493
2020-12-03

Inhibitors

#1234
20200377465
2020-12-03

Substituted piperazines as selective HDAC1,2 inhibitors

#1235
20200375969
2020-12-03

Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6

#1236
20200375946
2020-12-03

Inhibitors of metallo-beta-lactamases

#1237
20200369658
2020-11-26

Compounds

#1238
20200369657
2020-11-26

Substituted 1-methyl-1,2,3,4-tetrahydroisoquinoline molecules as PCSK9 allosteric binders

#1239
20200361963
2020-11-19

Pyridinamine-pyridone and pyrimidinamine- pyridone compounds

#1240
20200361927
2020-11-19

Benzenesulfonamide compounds and their use as therapeutic agents

#1241
20200361926
2020-11-19

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#1242
20200361920
2020-11-19

Isoxazole derivatives as FXR agonists and methods of use thereof

#1243
20200361895
2020-11-19

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

#1244
20200360521
2020-11-19

TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS

#1245
20200360348
2020-11-19

Compounds, compositions, and methods of increasing CFTR activity

#1246
20200354375
2020-11-12

Quinoxaline derivatives as adenosine receptor antagonists

#1247
20200354354
2020-11-12

Benzenesulfonamide compounds and their use as therapeutic agents

#1248
20200354341
2020-11-12

Sulfonamide carboxamide compounds

#1249
20200353101
2020-11-12

DNA-PK inhibitors

#1250
20200347034
2020-11-05

Compounds and their use for reducing uric acid levels

#1251
20200347025
2020-11-05

Compounds and compositions for inhibition of FASN

#1252
20200347020
2020-11-05

Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists

#1253
20200345716
2020-11-05

4-methylsulfonyl-substituted piperidine urea compounds

#1254
20200339586
2020-10-29

Compounds and their use as inhibitors of N-myristoyl transferase

#1255
20200339549
2020-10-29

CXCR2 antagonist

#1256
20200339545
2020-10-29

Compounds and their use for reducing uric acid levels

#1257
20200339537
2020-10-29

NOVEL COMPOUND AS INHIBITOR AGAINST BINDING OF PF34 PROTEIN TO NEDD4-1 PROTEIN AND USE THEREOF

#1258
20200339522
2020-10-29

Phenoxymethyl derivatives

#1259
20200339507
2020-10-29

Methods of synthesizing aztreonam derivatives

#1260
20200331920
2020-10-22

Amide substituted indole compounds useful as TLR inhibitors

#1261
20200331904
2020-10-22

3-AMINO-[1,2,4]-TRIAZOLE DERIVATIVES AND THEIR USE FOR CONTROLLING UNDESIRED PLANT GROWTH

#1262
20200331902
2020-10-22

Derivatives of luciferin and methods for their synthesis

#1263
20200331870
2020-10-22

MCL-1 inhibitors

#1264
20200331861
2020-10-22

Cannabinoid receptor mediating compounds

#1265
20200331860
2020-10-22

C-Met Modulators and Methods of Use

#1266
20200331847
2020-10-22

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

#1267
20200325128
2020-10-15

Compounds and methods useful in the treatment of a PRMT5-mediated disorder

#1268
20200317730
2020-10-08

TARGETED NITROXIDE AGENTS

#1269
20200317714
2020-10-08

Cyclic peroxides as prodrugs for selective delivery of agents

#1270
20200317691
2020-10-08

Compounds, Compositions and Methods

#1271
20200317659
2020-10-08

Method for producing optically active compound

#1272
20200317658
2020-10-08

Inhibiting ubiquitin specific peptidase 30

#1273
20200308173
2020-10-01

Inhibitors of kinase networks and uses thereof

#1274
20200308156
2020-10-01

Biguanide derivatives and their rearrangement products for use in the treatment of cancer

#1275
20200308110
2020-10-01

Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors

#1276
20200299307
2020-09-24

Androgen receptor modulating compounds

#1277
20200299261
2020-09-24

WNT signaling pathway inhibitors for treatments of disease

#1278
20200299237
2020-09-24

Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists

#1279
20200297721
2020-09-24

Type II raf kinase inhibitors

#1280
20200297710
2020-09-24

Chemical compounds

#1281
20200291041
2020-09-17

PCSK9 inhibitors and methods of use thereof

#1282
20200291014
2020-09-17

RAD51 inhibitors

#1283
20200289502
2020-09-17

PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY

#1284
20200289486
2020-09-17

Enantiomers of substituted thiazoles as antiviral compounds

#1285
20200289485
2020-09-17

Maleate salt of the free base of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof for the treatment of herpes viruses

#1286
20200289475
2020-09-17

Riluzole prodrugs and their use

#1287
20200284946
2020-09-10

ORGANIC OPTICAL MATERIAL

#1288
20200283441
2020-09-10

Compounds for improving mRNA splicing

#1289
20200283398
2020-09-10

USE OF SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI

#1290
20200283383
2020-09-10

MEK inhibitors and methods of their use

#1291
20200277288
2020-09-03

Microbiocidal Thiazole Derivatives

#1292
20200277267
2020-09-03

METHODS FOR TREATING VASCULAR LEAK SYNDROME

#1293
20200276180
2020-09-03

Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor

#1294
20200275657
2020-09-03

Microbiocidal quinoline (thio)carboxamide derivatives

#1295
20200275655
2020-09-03

Pyridinium salt and pest control agent

#1296
20200270274
2020-08-27

ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

#1297
20200270247
2020-08-27

Therapeutic compounds as inhibitors of the orexin-1 receptor

#1298
20200270240
2020-08-27

BENZOTHIAZOLE AND PYRIDOTHIAZOLE COMPOUNDS AS SUMO ACTIVATORS

#1299
20200270239
2020-08-27

Compounds, salts thereof and methods for treatment of diseases

#1300
20200270238
2020-08-27

Pyrimidinyloxy benzene derivatives as herbicides

#1301
20200267986
2020-08-27

Microbiocidal oxadiazole derivatives

#1302
20200262850
2020-08-20

SUBSTITUTED ASYMMETRIC UREAS AS MODULATORS OF GHRELIN RECEPTOR ACTIVITY

#1303
20200262831
2020-08-20

Factor XIIa inhibitors

#1304
20200262830
2020-08-20

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

#1305
20200262824
2020-08-20

Microbiocidal quinoline (thio)carboxamide derivatives

#1306
20200262801
2020-08-20

POLYMERIZABLE COMPOUND AND A PRODUCTION METHOD FOR SAME, POLYMERIZABLE COMPOSITION, POLYMER, OPTICAL FILM, OPTICAILLY ANISOTROPIC BODY, POLARIZING PLATE, DISPLAY DEVICE, ANTIREFLECTION FILM, AND COMPOUND AND USE FOR SAME

#1307
20200262796
2020-08-20

6-membered heterocyclic derivatives and pharmaceutical composition comprising the same

#1308
20200261436
2020-08-20

Oxazolidinones as taro inhibitors

#1309
20200261411
2020-08-20

TRPV4 antagonists

#1310
20200255446
2020-08-13

Compositions and methods for treating cancer

#1311
20200255417
2020-08-13

Thiophene compounds, process for synthesis and use thereof

#1312
20200255407
2020-08-13

Quinazolines as potassium ion channel inhibitors

#1313
20200255400
2020-08-13

Microbiocidal picolinamide derivatives

#1314
20200253937
2020-08-13

5-DEUTERO-THIAZOLIDINE-2,4-DIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME

#1315
20200247814
2020-08-06

Hetero-halo inhibitors of histone deacetylase

#1316
20200247795
2020-08-06

Compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same

#1317
20200247765
2020-08-06

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#1318
20200247764
2020-08-06

Pharmacophores, compounds and methods having application in the treatment of cancer through inhibition of CYP17A1 and CYP19A1

#1319
20200247755
2020-08-06

ETHERS, SECONDARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

#1320
20200247754
2020-08-06

Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use

#1321
20200246274
2020-08-06

Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy

#1322
20200239460
2020-07-30

TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF

#1323
20200239458
2020-07-30

Inhibitors of protein kinases

#1324
20200239457
2020-07-30

5-DEUTERO-THIAZOLIDINYLDIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME

#1325
20200239445
2020-07-30

2,4-diamino-6-ethylpyrimidine derivatives with antimalarial activities against

#1326
20200239433
2020-07-30

Pyrrole and pyrazole compounds and methods of use thereof

#1327
20200239430
2020-07-30

Bi-functional compounds and methods for targeted ubiquitination of androgen receptor

#1328
20200239415
2020-07-30

EBNA1 inhibitors and methods using same

#1329
20200237763
2020-07-30

3-hydroxy-quinazoline-2,4-dione derivatives and their use as nuclease modulators

#1330
20200231584
2020-07-23

PCSK9 inhibitors and methods of use thereof

#1331
20200231571
2020-07-23

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

#1332
20200231542
2020-07-23

Cyanopyrrolidines as dub inhibitors for the treatment of cancer

#1333
20200225217
2020-07-16

Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof

#1334
20200223845
2020-07-16

Viral replication inhibitors

#1335
20200223839
2020-07-16

FLUORO-CONTAINING COMPOUNDS, USE AND PREPARATION THEREOF

#1336
20200223821
2020-07-16

Phenylpyridine derivative and pharmaceutical composition comprising the same

#1337
20200223819
2020-07-16

Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer

#1338
20200223818
2020-07-16

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

#1339
20200216490
2020-07-09

PPAR agonists and methods of use thereof

#1340
20200216468
2020-07-09

Heterocycle amines and uses thereof

#1341
20200216437
2020-07-09

RAD51 inhibitors

#1342
20200216435
2020-07-09

BICYCLIC HETEROAROMATIC AMIDE COMPOUNDS FOR USE IN THERAPY

#1343
20200216434
2020-07-09

BENZOFURAN UREAS OR CARBAMATES AND HETEROAROMATIC ANALOGUES THEREOF FOR USE IN THERAPY

#1344
20200216432
2020-07-09

SULFONAMIDE DERIVATIVES AS STAT3 INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

#1345
20200216397
2020-07-09

5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#1346
20200215206
2020-07-09

Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof

#1347
20200207775
2020-07-02

Mitoketoscins: mitochondrial-based therapeutics targeting ketone metabolism in cancer cells

#1348
20200207753
2020-07-02

Tripartite androgen receptor eliminators, methods and uses thereof

#1349
20200207730
2020-07-02

METHODS FOR TREATING VASCULAR LEAK SYNDROME

#1350
20200199126
2020-06-25

Cyanopyrrolidine derivatives with activity as inhibitors of USP30

#1351
20200199117
2020-06-25

Crystalline form of a BACE inhibitor, compositions, and use

#1352
20200199115
2020-06-25

Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof

#1353
20200199113
2020-06-25

Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists

#1354
20200199111
2020-06-25

Delta-opioid receptor agonists

#1355
20200199107
2020-06-25

Modulators of estrogen receptor proteolysis and associated methods of use

#1356
20200199098
2020-06-25

Diarylhydantoin compounds and methods of use thereof

#1357
20200196606
2020-06-25

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#1358
20200196602
2020-06-25

Heteroarylphenylaminoquinolines and analogues

#1359
20200190077
2020-06-18

NEUROPROTECTIVE HYDRAZIDES

#1360
20200190072
2020-06-18

Compounds, compositions, and methods for increasing CFTR activity

#1361
20200190066
2020-06-18

Compound used as autophagy regulator, and preparation method therefor and uses thereof

#1362
20200190030
2020-06-18

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

#1363
20200190019
2020-06-18

PPAR agonists

#1364
20200181137
2020-06-11

Method of preparing glucosylceramide synthase inhibitors

#1365
20200181130
2020-06-11

Compositions and methods for inhibition of the JAK pathway

#1366
20200181129
2020-06-11

Carbazole compounds and methods of use thereof

#1367
20200181117
2020-06-11

SUBSTITUTED 3-HETEROARYLOXY-1H-PYRAZOLES AND SALTS THEREOF AND THEIR USE AS HERBICIDAL ACTIVE SUBSTANCES

#1368
20200181100
2020-06-11

Microbiocidal oxadiazole derivatives

#1369
20200181090
2020-06-11

6-aminoisoquinoline compounds

#1370
20200181086
2020-06-11

1-cyano-pyrrolidine compounds as USP30 inhibitors

#1371
20200179376
2020-06-11

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE

#1372
20200179360
2020-06-11

Deuterium-enriched pioglitazone

#1373
20200172531
2020-06-04

Compound and pharmaceutical composition containing the same

#1374
20200172530
2020-06-04

Small Molecule Sensitization of BAX Activation for Induction of Cell Death

#1375
20200172517
2020-06-04

Pyridazinone compound or its salt, and herbicide containing it

#1376
20200172516
2020-06-04

Compounds

#1377
20200172499
2020-06-04

INHIBITORS OF CYCLIN-DEPENDENT KINASES

#1378
20200172498
2020-06-04

Microbiocidal oxadiazole derivatives

#1379
20200172492
2020-06-04

Pharmaceutical compound

#1380
20200172491
2020-06-04

SUBSTITUTED 5-(HET-)ARYLPYRAZOLAMIDES AND SALTS THEREOF AND THEIR USE AS HERBICIDAL ACTIVE SUBSTANCES

#1381
20200172483
2020-06-04

HETEROCYCLIC SMALL MOLECULE MODULATORS OF HUMAN STING

#1382
20200165267
2020-05-28

Thiazolyl-containing compounds for treating proliferative diseases

#1383
20200165262
2020-05-28

Quinazoline and indole compounds to treat medical disorders

#1384
20200165237
2020-05-28

Five membered-aminoheterocycle and 5,6-or 6,6-membered bicyclic aminoheterocyclic inhibitors of rock for the treatment of heart failure

#1385
20200165235
2020-05-28

NADPH oxidase 4 inhibitors

#1386
20200165206
2020-05-28

Inhibitors of Rho associated coiled-coil containing protein kinase

#1387
20200163935
2020-05-28

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

#1388
20200157113
2020-05-21

Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors

#1389
20200157089
2020-05-21

Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents

#1390
20200157069
2020-05-21

Prodrugs of riluzole and their method of use

#1391
20200157066
2020-05-21

Sulfonamide compound or salt thereof

#1392
20200157052
2020-05-21

S1P3 antagonists

#1393
20200155562
2020-05-21

Aryl-or heteroaryl-substituted benzene compounds

#1394
20200155538
2020-05-21

Quinoline derivatives

#1395
20200155511
2020-05-21

ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE

#1396
20200148705
2020-05-14

Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) protein

#1397
20200148688
2020-05-14

Mitoketoscins: mitochondrial-based therapeutics targeting ketone metabolism in cancer cells

#1398
20200148673
2020-05-14

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

#1399
20200148651
2020-05-14

Substituted phenyloxazolidinones for antimicrobial therapy

#1400
20200148638
2020-05-14

Mast-cell modulators and uses thereof

#1401
20200147066
2020-05-14

Heteroaryl sulfonamides and CCR2/CCR9

#1402
20200140460
2020-05-07

ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS

#1403
20200140459
2020-05-07

Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors

#1404
20200140425
2020-05-07

COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS

#1405
20200140407
2020-05-07

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

#1406
20200140402
2020-05-07

CFTR regulators and methods of use thereof

#1407
20200138827
2020-05-07

SMALL MOLECULE MODULATORS OF HUMAN STING

#1408
20200138780
2020-05-07

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

#1409
20200131171
2020-04-30

Dual mechanism inhibitors for the treatment of disease

#1410
20200131170
2020-04-30

Compounds for pain treatment, compositions comprising same, and methods of using same

#1411
20200131169
2020-04-30

1,3-thiazol-2-yl substituted benzamides

#1412
20200131168
2020-04-30

Hepatitis B core protein modulators

#1413
20200131167
2020-04-30

Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels

#1414
20200131157
2020-04-30

Pyrazole derivatives for the treatment of cystic fibrosis

#1415
20200131156
2020-04-30

ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS

#1416
20200131144
2020-04-30

AMINE OR (THIO)AMIDE CONTAINING LXR MODULATORS

#1417
20200129484
2020-04-30

RAD51 inhibitors

#1418
20200123148
2020-04-23

Protein kinase inhibitors

#1419
20200123147
2020-04-23

THIAZOLE COMPOUNDS USEFUL AS PRMT5 INHIBITORS

#1420
20200123145
2020-04-23

N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof

#1421
20200123108
2020-04-23

Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists

#1422
20200123105
2020-04-23

Hepatitis B capsid assembly modulators

#1423
20200116896
2020-04-16

Composition, film, lens, solid state imaging element, and compounds

#1424
20200115374
2020-04-16

Modulators of indoleamine 2,3-dioxygenase

#1425
20200115356
2020-04-16

Modulation of Bacterial Quorum Sensing With Synthetic Ligands

#1426
20200115354
2020-04-16

THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF

#1427
20200115353
2020-04-16

NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA

#1428
20200115347
2020-04-16

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#1429
20200115343
2020-04-16

FUSED-BICYCLIC ARYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS

#1430
20200115339
2020-04-16

EFFLUX-PUMP INHIBITORS AND THERAPEUTIC USES THEREOF

#1431
20200113904
2020-04-16

Methods for treating Huntington's disease

#1432
20200113887
2020-04-16

4-methylsulfonyl-substituted piperidine urea compounds

#1433
20200109167
2020-04-09

Small molecule DCN1 inhibitors and therapeutic methods using the same

#1434
20200109120
2020-04-09

PKM2 modulators and methods for their use

#1435
20200109110
2020-04-09

Sulfur derivatives as chemokine receptor modulators

#1436
20200108080
2020-04-09

COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES

#1437
20200102299
2020-04-02

Substituted isoindole allosteric EGFR inhibitors

#1438
20200102292
2020-04-02

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

#1439
20200102290
2020-04-02

Aryl cyclopropyl-amino-isoquinolinyl amide compounds

#1440
20200102288
2020-04-02

WDR5 inhibitors and modulators

#1441
20200102284
2020-04-02

Tricyclic spiro compound

#1442
20200102275
2020-04-02

Carboxylic acid derivative as ATR receptor antagonist

#1443
20200101047
2020-04-02

Inhibitors of integrated stress response pathway

#1444
20200095259
2020-03-26

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

#1445
20200095239
2020-03-26

N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors

#1446
20200087291
2020-03-19

Quinoline and isoquinoline derivatives for treating pain and pain related conditions

#1447
20200087270
2020-03-19

Compounds and compositions for treating conditions associated with NLRP activity

#1448
20200087264
2020-03-19

Selective ligand for dopamine D3 receptor, preparation method therefor, and pharmaceutical application thereof

#1449
20200085824
2020-03-19

Small molecule regulators of steroid receptor coactivators and methods of use thereof

#1450
20200085820
2020-03-19

2,4-pyrimidinediamine compounds and their uses

#1451
20200085794
2020-03-19

Riluzole prodrugs and their use

#1452
20200077658
2020-03-12

Pesticidal Compounds

#1453
20200071315
2020-03-05

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

#1454
20200062790
2020-02-27

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#1455
20200062708
2020-02-27

Sulfonamides as inhibitors of the uptake of extracellular citrate

#1456
20200055845
2020-02-20

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

#1457
20200055825
2020-02-20

Compounds and methods for the targeted degradation of androgen receptor

#1458
20200054623
2020-02-20

Chemokine CXCR4 receptor modulators and uses related thereto

#1459
20200052217
2020-02-13

Conjugated polymers based on terthiophene and their applications

#1460
20200049699
2020-02-13

T1R HETERO-OLIGOMERIC TASTE RECEPTORS, CELL LINES THAT EXPRESS SAID RECEPTORS, AND TASTE COMPOUNDS

#1461
20200048276
2020-02-13

MYC MODULATORS AND USES THEREOF

#1462
20200048240
2020-02-13

Acyl sulfonamide NaV1.7 inhibitors

#1463
20200048213
2020-02-13

Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound

#1464
20200048197
2020-02-13

Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators

#1465
20200048195
2020-02-13

SUBSTITUTED PYRROLIDINE CARBOXAMIDE COMPOUNDS

#1466
20200048194
2020-02-13

SUBSTITUTED BENZAMIDES

#1467
20200040106
2020-02-06

Hybridoma cell line of secreting meloxicam monoclonal antibodies and application thereof

#1468
20200039976
2020-02-06

Compounds and methods for inhibiting fascin

#1469
20200039975
2020-02-06

Processes for the preparation of a BACE inhibitor

#1470
20200039961
2020-02-06

SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS

#1471
20200039945
2020-02-06

Compounds

#1472
20200039944
2020-02-06

Cathepsin-D and angiogenesis inhibitors and compositions thereof for treating breast cancer

#1473
20200037613
2020-02-06

Insecticidal compounds

#1474
20200031817
2020-01-30

Insecticidal compounds

#1475
20200031770
2020-01-30

MEK INHIBITORS AND METHODS OF THEIR USE

#1476
20200030456
2020-01-30

Quinone-containing conjugates

#1477
20200024270
2020-01-23

Compounds for treatment of cancer

#1478
20200024269
2020-01-23

Compounds having estrogen receptor alpha degradation activity and uses thereof

#1479
20200024268
2020-01-23

Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell

#1480
20200024267
2020-01-23

Chromobox protein inhibitors and uses thereof

#1481
20200024236
2020-01-23

Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase

#1482
20200017523
2020-01-16

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

#1483
20200017488
2020-01-16

Heterocyclic inhibitors of the sodium channel

#1484
20200017478
2020-01-16

Compounds and their use for reducing uric acid levels

#1485
20200017477
2020-01-16

Compounds and their use for reducing uric acid levels

#1486
20200017459
2020-01-16

4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same

#1487
20200017458
2020-01-16

Compounds and compositions for inhibition of FASN

#1488
20200017455
2020-01-16

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitors

#1489
20200016140
2020-01-16

Azole compounds as ubiquitin-specific protease USP7 inhibitors

#1490
20200010464
2020-01-09

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

#1491
20200010459
2020-01-09

Piperazine derivatives for influenza virus inhibitions

#1492
20200010420
2020-01-09

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

#1493
20200010415
2020-01-09

Urea derivative or pharmacologically acceptable salt thereof

#1494
20200010414
2020-01-09

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#1495
20200010407
2020-01-09

Phenyl and pyridinyl hydroxamic acids

#1496
20200009612
2020-01-09

Display inserts, overlays, and graphical user interfaces for multimedia systems

#1497
20200009140
2020-01-09

Pyridyl derivatives as bromodomain inhibitors

#1498
20200008425
2020-01-09

FUNGICIDAL PYRAZOLES

#1499
20200002326
2020-01-02

Sulfoximine glycosidase inhibitors

#1500
20200002325
2020-01-02

Process for making Hepatitis B core protein modulators